How health care system works


European Regulatory Language Requirements

Sustaining competitive advantage within the- LatvianLithuania - LithuanianMalta
medical device industry involves a global- English & MaltesePoland -
product strategy that recognizes the EuropeanPolishRomania - RomanianSlovakia -
market's substantial global market share.SlovakSlovenia - SlovenianTurkey
Estimated at 30% of the global medical device- TurkishEU Member State Official Languages
market, the European community poses
increasing regulatory challenges for medicalDepending on the extent of the product's
device manufacturers. Regulations controllingpresence in the European Union, there are
the manufacturing, marketing and usage ofcurrently up to 12 languages required for the
medical devices in the EU are forcinglabeling, IFUs, documentation, and marketing
manufacturers to incorporate languagematerials in accordance with the IVDD and MDD
translation and localization into globalnecessary for CE mark as displayed in TABLE I
development strategies as individual Member.As the EU continues to grow and the trading
States demand product information in thebarriers dissolve, prospective Member States
language of the local user.An exigentare actively transitioning regulations to
regulatory hurdle facing the medical devicemeet the CE mark criteria, requiring new
industry is the European Union's IVDD 98/79languages. A midday regulatory shadow to the
EC directive which went into effect DecemberEU, European Free Trade Association (EFTA)
7, 2003. Formulated five years ago, the IVDDcountries of Iceland, Liechtenstein and
98/79/EC dictates that as of the DecemberNorway are aggressively enforcing the CE
date, all new in vitro medical devices mustmark, shown in TABLE II . Although not a
bear CE Marks or face refusal into themember of the EFTA, Switzerland is also
European market or regulatory, criminal orenforcing medical device CE mark.In addition
product/civil liability.What is the guidingto the EFTA, 13 more countries have applied
principle behind the new directive?The IVDDfor membership in the European Union.
Directive virtually eliminates the costlyPerforming a parallel migration to the
regulations imposed by individual memberEuropean Union's regulatory requirements,
states. Manufacturers who comply with theseveral of these future Member States are
Directive will be able to apply the CE markactively adopting the CE Mark to ensure goods
to their products and market them freelycan freely move throughout the European
within  member  states  of  the  EU.Union, including Poland, Romania, Slovakia,
and  Turkey,  seeTABLE  III  .
The IVDD (In Vitro Diagnostic Devices
Directive) is one of three associatedGlobal Harmonization and International
directives issued by the European Union,Quality  Standards
which together cover all forms of medical
equipment with the intent to ensure that onlyIn 1998, the United States and the European
safe and effective products are sold in theUnion introduced the New Transatlantic
European market. The directives clearlyAgreement (NTA) to improve economic
outline regulations regarding manufacturing,cooperation between the two economic powers.
importing, and marketing of such devices. TheIn this landmark accord resides the Mutual
IVDD specifically involves in vitro ( in anRecognition Agreement (MRA) that acknowledges
artificial environment outside the livingthe regulatory standards of the respective
organism ) medical devices that examine humaneconomic bodies-an area of transition that
fluids or tissue samples to identify,affects the medical device industry. The
diagnose, and monitor medical conditions. TheEuropean Union medical device directives
IVDD 98/79/EC brings in vitro devices in linerefer to ISO 9001 as the series of quality
with other medical devices already regulatedmanagement standards and the US refers to
by the EU, the MDD (Medical DevicesFDA's Quality System Requirements and all
Directive) and the AIMDD (Active Implantablecorresponding good manufacturing (GMP)
Medical Devices Directive).The IVDD and itpractices regulations. Benefiting medical and
sibling directives apply progressivepharmaceutical companies, both quality
regulatory requirements to medical devicessystems have made considerable efforts to
and their accessories depending on thesynchronize their requirements further
classified risk they present to the user,increasing the common ground between quality
defined in the directive as Class I throughsystems in North America and Europe.ISO
III. Unless the classified product is a(International Organization for
low-risk Class I device that does not containStandardization)
any sterile packaging or a measuring
function, manufacturers require a third-partyAdding to the pressure the current ISO
Notified Body to independently certify the9000:1994 standard is transitioning to a new
device's compliance to the Directive'sISO: 9000:2000 series effective December 14th
Essential Requirements (a.k.a. Annex I)-goodof this year. However, as of May 15, 2003,
faith is not enough. Additionally, in a newonly 19.5% of the total ISO registered North
twist within the Directive, the authorizedAmerican companies had completed their
representative shown on the device label forregistration process. This is essential in
Class I devices manufactured outside the EUthe entire chain of requirements. The new
may be required to produce the technicalstandard is a consolidation of ISO 9001 and
file, including copies of all translated9002, and has more of a customer satisfaction
materials. Any incorrect labeling orand continuous improvement focus not present
instructions for use may lead to regulatoryin previous versions.GMP (Good Manufacturing
criminal or product/civil liability in thePractices)
EU.Any medical device manufacturer wishing to
market its products in the European Union isIn December 1978, the FDA Good Manufacturing
fully responsible for complying with thePractices (GMP) Regulation became effective,
corresponding safety and administrativeestablishing Quality System Requirements for
Essential Requirements and must display theproducts regulated under the FDA, including
CE mark of conformity as stated in Article 16medical devices. In 1990, the Safe Medical
of the IVDD 98/79/EC . If that's not a redDevices Act (SMDA) expanded the GMP to
flag, consider the next regulatory deadlineinclude design, manufacturing, packaging,
facing in vitro device manufacturers: Bylabeling, storage, installation and servicing
December 7, 2005, the European Union will notof all finished medical devices.Exporting
only require a CE mark to legally market aAmerican  Medical  Devices
product, but will require a CE mark to
legally put a medical device into service-aAny medical device in the US market may not
requirement much more critical to the revenuebe legally exported anywhere in the world
of manufacturers and healthcare!CE Mark: Awithout prior FDA notification or approval;
passport  to  the  European  Unionhowever, for a device to be legally
distributed  in  the  US,  the FDA requires:
An abbreviation of a French phase
"Conformite Europeene," the CE mark indicatesRegistration of both the medical device and
that the medical device manufacturer hasmanufacturing site- Authorization for
conformed to all the obligations set forth bycommercial distribution through either a
the Directive 98/79/EC of the European510(k) pre-market notification or a
Parliament. Affixing this multinationalPre-market Approval (PMA) application
standardized mark to a product will allow anydepending upon the classification of the
global manufacturer a "passport" to freelydevice- Compliance with FDA labeling
distribute their products within the Europeanrequirements- Manufacturing compliance with
Union without additional quality testing orthe FDA's GoodManufacturing Practices
approvals. Reflective of the 1946 Treaty of(GMP)While the FDA does not place any
Rome, the CE mark is a conformity tool thatrestrictions on the export of these devices,
is intended to further promote thecertain countries require an Export
establishment of a single market where theCertificate that the manufacturer and its
free movement of goods, persons, services anddevices are indeed in compliance with FDA
capital are ensured. Fundamentally, the CEregulations. Medical devices that do not have
mark and the medical device directives removea 510(k), PMA, or are solely manufactured for
many regulatory hurdles while providingexport may by approved for exportation by the
stronger regulations for smaller countries;FDA through Section 801(e)(1) of the FFDCA;
however, it also creates critical languagehowever, the manufacturer may experience
compliance issues that may prove to be costlyregulatory difficulties depending on the
for manufacturers. Regardless of the intendedindividual country's requirements of an FDA
global harmonization, participating countriesExport Certificate, which, as stated above,
are preserving their national cultures andrequire a 510 (k) or a PMA.Sorting through
languages by requiring product information inthe regulations to achieve global product
their own local languages.IVDD, MDD &delivery
AIMD...more  languages!
The question facing medical device
Depending on device classification, tomanufacturers in the current global market is
legally display the CE mark, the IVDD, MDD,how to meet all language requirements in the
and AIMD all mandate that manufacturersmost cost-effective, regulatory compliant
provide all labeling, information for usage,manner. Managing regulations and translations
documentation, and marketing materials in theare among the most critical aspects of
official language(s) of the end-user's Memberdeveloping and marketing products for the
State, taking into account the training andlife sciences industries. Any mistake, no
knowledge of the potential users as stated inmatter how minor, can delay product
Article 4, Paragraph 4, IVDD 98/79/ECapprovals, launches, or cause widespread
.Documentation Translation Requirements -public relations disasters. Therefore,
Conformity  Assessment  Proceduresdeveloping translation and localization
processes has become a competitive advantage
Manufacturers are required to translate thefor global manufacturers of medical
documentation relating to the production,devices.Working closely with a translation
testing and quality processes in the officialand localization vendor who specializes in
language(s) of the Member State in which themedical language services is an important
procedures are carried out as stated instep in conquering the ever-changing
Article 9, Paragraph 11 of the IVDD 98/79/EC.international regulatory process. The choice
Depending on device classification, theseof the translation provider is extremely
documents must include a number of requiredimportant to ensure that translations are
disclosures dependent on the productaccurate, consistent and technically correct,
classification.as well as harmonious with the manufacturers'
processes.Medical language service providers
Depending on marketing and distributionshould-at the very least-provide documented
objectives, some products may require up toprocesses that involve native-speaking
12 languages, creating complicatedlinguists that have expertise in both medical
multilingual product labeling and IFUtranslation and the medical industry. To
challenges. There can be over 20 informationdeliver consistency, quality and reduced
pieces required for each product label ofcosts, the language service provider should
IFU, depending on the classification asalso implement terminology management tools
detailed in Annex I, Part B, Section 8 of theand computer-assisted translation solutions
Directive.Table  Iin concert with the team of human
translators.Conclusion
Official Language(s) of EU Member
StatesMember State OfficialComplex and ever-changing international
language(s)Austria - GermanBelgium -regulations controlling the marketing and
Dutch, French & GermanDenmark -usage of medical devices are forcing
DanishFinland - FinnishFrance -manufacturers to incorporate language
FrenchGermany - GermanGreece -translation and localization into global
GreekIreland - EnglishItaly -development strategies. The European Union
ItalianLuxembourg - French, German,members currently require that all product
LuxembourgishNetherlands - DutchPortugalinformation be in the official language of
- PortugueseSpain -the local users and the diversity of this
SpanishSweden - SwedishUnitedeconomic area is only growing to include more
Kingdom - EnglishTable  IIregulations and official languages. A
simultaneous global release of medical
Official  Language(s) of EFTA Member Statesdevices involving up to 12 languages in
Europe alone makes this issue as critical as
Member State Official language(s)Iceland -the  intended purpose of the medical device.
IcelandicLiechtenstein - GermanNorway
- NorwegianSwitzerland - German,Medical device manufacturers can
French & Italian( Switzerland is not a EFTAcost-effectively market their products
member  but  requires  translation)Table  IIIglobally while satisfying international
regulatory requirements by partnering with
Official Language(s) of Member StatesNet-Translators a qualified language service
Applying  For  EU  Membershipprovider in the very early stages of product
development. The right language partner can
Member State Official language(s) Bulgariaturn what may now appear as a chaos of
- BulgarianCyprus - GreekCzechregulatory requirements into a successful
Republic - CzechEstonia -international product release.
EstonianHungary - HungarianLatvia



1 A B C D 58 59 60 61 62 63 64 66 67 68 69 70 71 72 74 75 76 77 78 79 80 81 84 85 87 88 89 91 92 94 95 96 97 98 99 100 101 102 103 104 106 107 108 109 110